Eagle Pharmaceuticals Inc (EGRX)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Eagle Pharmaceuticals Inc (EGRX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-06-30	2023-03-31
기간	3개월	3개월
Revenues	2.50% 64.65	66.31
Cost Of Revenue	2.55% 16.86	17.30
Gross Profit	2.48% 47.79	49.01
Operating Expenses	0.68% 37.48	37.23
Interest Income/Expense	4.49% 1.448	1.516
Benefits Costs and Expenses	1.29% 55.35	56.07
Costs And Expenses	0.35% 54.34	54.53
Operating Income/Loss	12.48% 10.30	11.77
Nonoperating Income/Loss	34.76% -1.006	-1.542
Income/Loss From Continuing Operations Before Tax	9.12% 9.298	10.23
Income Tax Expense/Benefit	7.74% 4.134	4.481
Income/Loss From Continuing Operations After Tax	10.19% 5.164	5.75
Net Income/Loss	10.19% 5.164	5.75
Preferred Stock Dividends And Other Adjustments	-	-
Attributable To Noncontrolling Interest	-	-
Basic Average Shares	0.24% 13.09	13.06
Diluted Average Shares	0.01% 13.15	13.15
Basic Earnings Per Share	11.36% 0.39	0.44
Diluted Earnings Per Share	11.36% 0.39	0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-

ALKS

$31.57

0.57%

ELAN

$11.52

3.76%

LNTH

$88.71

2.41%

NBIX

$122.62

18.53%

VTRS

$10.73

1.56%

ITCI

$127.01

0.09%